Clearpoint Neuro rises as preliminary quarterly revenue beats estimates
09/01/2024 11:16
** Shares of Clearpoint Neuro CLPT.O rise 10.1% to $6.95
premarket
** Late Monday, co posted preliminary Q4 rev of $6.8 mln
that beat Wall Street estimates of $6.22 mln - LSEG
** Medical device maker sees its 2024 rev between $28 mln
and $32 mln vs avg of analysts' estimates of $30.4 mln
** CLPT stock fell 19.8% in 2023
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))